Imatinib in small cell lung cancer (Q40574323)

21 September 2017

Imatinib in small cell lung cancer (English)

1 reference

21 September 2017

1 reference

1

Jean-Charles Soria

0 references

Thierry Le Chevalier

series ordinal

3

object named as

Thierry Le Chevalier

1 reference

21 September 2017

Bruce E Johnson

2

1 reference

21 September 2017

1 August 2003

1 reference

21 September 2017

1 reference

21 September 2017

41 Suppl 1

1 reference

21 September 2017

S49-53

1 reference

21 September 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

Small cell lung cancer: state-of-the-art therapy in 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

Platelet-derived growth factor receptors: a therapeutic target in solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900142-9

7 January 2021

10.1016/S0169-5002(03)00142-9

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

12867062